Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0480-3290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 0480-3290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

1 (Image 2)

1 (Image 2)
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

Carton (Image 4)

Carton (Image 4)
This text provides information about Paclitaxel Protein-Bound Particles for injectable suspension. It seems to be detailing the formulation and composition of the product. The text mentions albumin-bound particles and some technical details related to the suspension. Additional information about the product's characteristics or usage may be available but is not visible in this portion of the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.